171 related articles for article (PubMed ID: 37267716)
1. Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma.
Sahara S; Warner KA; Herzog AE; Zhang Z; Nör JE
Oral Oncol; 2023 Jul; 142():106437. PubMed ID: 37267716
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas.
Nör F; Warner KA; Zhang Z; Acasigua GA; Pearson AT; Kerk SA; Helman JI; Sant'Ana Filho M; Wang S; Nör JE
Clin Cancer Res; 2017 Feb; 23(4):1036-1048. PubMed ID: 27550999
[No Abstract] [Full Text] [Related]
3. mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells.
Nakano T; Warner KA; Oklejas AE; Zhang Z; Rodriguez-Ramirez C; Shuman AG; Nör JE
J Dent Res; 2021 Apr; 100(4):377-386. PubMed ID: 33073679
[TBL] [Abstract][Full Text] [Related]
4. BH3-mimetic small molecule inhibits the growth and recurrence of adenoid cystic carcinoma.
Acasigua GA; Warner KA; Nör F; Helman J; Pearson AT; Fossati AC; Wang S; Nör JE
Oral Oncol; 2015 Sep; 51(9):839-47. PubMed ID: 26121939
[TBL] [Abstract][Full Text] [Related]
5. UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.
Warner KA; Oklejas AE; Pearson AT; Zhang Z; Wu W; Divi V; Rodriguez-Ramirez C; Castilho RM; Polverini PJ; Nör JE
Oral Oncol; 2018 Dec; 87():21-28. PubMed ID: 30527239
[TBL] [Abstract][Full Text] [Related]
6. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
Kerk SA; Finkel KA; Pearson AT; Warner KA; Zhang Z; Nör F; Wagner VP; Vargas PA; Wicha MS; Hurt EM; Hollingsworth RE; Tice DA; Nör JE
Clin Cancer Res; 2017 May; 23(10):2516-2527. PubMed ID: 27780858
[No Abstract] [Full Text] [Related]
7. Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma.
Warner KA; Nör F; Acasigua GA; Martins MD; Zhang Z; McLean SA; Spector ME; Chepeha DB; Helman J; Wick MJ; Moskaluk CA; Castilho RM; Pearson AT; Wang S; Nör JE
Clin Cancer Res; 2016 Jul; 22(14):3550-9. PubMed ID: 26936915
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.
Nör C; Zhang Z; Warner KA; Bernardi L; Visioli F; Helman JI; Roesler R; Nör JE
Neoplasia; 2014 Feb; 16(2):137-46. PubMed ID: 24709421
[TBL] [Abstract][Full Text] [Related]
9. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells.
Herzog AE; Warner KA; Zhang Z; Bellile E; Bhagat MA; Castilho RM; Wolf GT; Polverini PJ; Pearson AT; Nör JE
Cell Death Dis; 2021 Oct; 12(11):988. PubMed ID: 34689150
[TBL] [Abstract][Full Text] [Related]
10. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.
Adams A; Warner K; Pearson AT; Zhang Z; Kim HS; Mochizuki D; Basura G; Helman J; Mantesso A; Castilho RM; Wicha MS; Nör JE
Oncotarget; 2015 Sep; 6(29):26633-50. PubMed ID: 26449187
[TBL] [Abstract][Full Text] [Related]
11. p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness.
Rodriguez-Ramirez C; Zhang Z; Warner KA; Herzog AE; Mantesso A; Zhang Z; Yoon E; Wang S; Wicha MS; Nör JE
Clin Cancer Res; 2022 Nov; 28(21):4757-4770. PubMed ID: 36048559
[TBL] [Abstract][Full Text] [Related]
12. MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.
Panaccione A; Zhang Y; Ryan M; Moskaluk CA; Anderson KS; Yarbrough WG; Ivanov SV
Stem Cell Res; 2017 May; 21():160-166. PubMed ID: 28500913
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autophagy enhances cisplatin cytotoxicity in human adenoid cystic carcinoma cells of salivary glands.
Ma B; Liang LZ; Liao GQ; Liang YJ; Liu HC; Zheng GS; Su YX
J Oral Pathol Med; 2013 Nov; 42(10):774-80. PubMed ID: 23590333
[TBL] [Abstract][Full Text] [Related]
14. NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma.
Panaccione A; Chang MT; Carbone BE; Guo Y; Moskaluk CA; Virk RK; Chiriboga L; Prasad ML; Judson B; Mehra S; Yarbrough WG; Ivanov SV
Clin Cancer Res; 2016 Apr; 22(8):2083-95. PubMed ID: 27084744
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
[TBL] [Abstract][Full Text] [Related]
16. FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin.
McDermott SC; Rodriguez-Ramirez C; McDermott SP; Wicha MS; Nör JE
Oncotarget; 2018 May; 9(38):25148-25165. PubMed ID: 29861860
[TBL] [Abstract][Full Text] [Related]
17. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE
Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional collagen scaffold enhances the human adenoid cystic carcinoma cancer stem cell and epithelial-mesenchymal transition properties.
Liu LJ; Zhang J; Xiao ZF; Dai B; Sun MY; Chen L; Chen B
J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):772-80. PubMed ID: 24142425
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study.
Savarese T; Abate A; Basnet RM; Lorini L; Gurizzan C; Tomasoni M; Lombardi D; Tomasini D; Zizioli D; Memo M; Berruti A; Bonini SA; Sigala S; Bossi P
Sci Rep; 2022 Jun; 12(1):9951. PubMed ID: 35705678
[TBL] [Abstract][Full Text] [Related]
20. Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid Carcinoma.
Andrews A; Warner K; Rodriguez-Ramirez C; Pearson AT; Nör F; Zhang Z; Kerk S; Kulkarni A; Helman JI; Brenner JC; Wicha MS; Wang S; Nör JE
Clin Cancer Res; 2019 Mar; 25(5):1588-1600. PubMed ID: 30498096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
